Irisin, an Emerging Diagnosis Marker in Haemodialysis Patients: Response to the Comment of Sah and Mehta on “Irisin: A Promising Diagnostic Biomarker at the Interface Between Systemic Inflammation and Skeletal Muscle Dysfunction in Haemodialysis Patients”

Documenti analoghi

• Irisin: A Promising Diagnostic Biomarker at the Interface Between Systemic Inflammation and Skeletal Muscle Dysfunction in Haemodialysis Patients
  di: Rômulo D. Novaes, et al.
  Pubblicazione: (2025)
• Comment on “Irisin: A Promising Diagnostic Biomarker at the Interface Between Systemic Inflammation and Skeletal Muscle Dysfunction in Haemodialysis Patients”
  di: Ranjana Sah, et al.
  Pubblicazione: (2025)
• Association Between Cognitive and Physical Functions in Patients Undergoing Haemodialysis
  di: Yu Shimano, et al.
  Pubblicazione: (2026)
• Nationwide Trends in Chronic Haemodialysis: Factors Influencing Patient Survival and Outcomes in Thailand
  di: Bancha Satirapoj, et al.
  Pubblicazione: (2026)
• Gender Differences in the Prevalence and Associated Factors of Sarcopenia Among Maintenance Haemodialysis Patients in Vietnam
  di: Minh Truong Do, et al.
  Pubblicazione: (2025)